ORAL-CONTRACEPTIVES AND THE RISK OF CARDIOVASCULAR-DISEASE

被引：0

作者：

不详

机构：

来源：

MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 1983年 / 25卷 / 640期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：69 / 70

页数：2

共 9 条

[1] SERUM HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL IN WOMEN USING ORAL-CONTRACEPTIVES, ESTROGENS AND PROGESTINS [J].

BRADLEY, DD ;

WINGERD, J ;

PETITTI, DB ;

KRAUSS, RM ;

RAMCHARAN, S .

NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (01) :17-20

[2]

DICKEY RP, 1983, CREATIVE INFOMATICS, P32

[3]

KAY CR, 1982, AM J OBSTET GYNECOL, V142, P762

[4]

LAYDE P M, 1981, Lancet, V1, P541

[5]

MEADE TW, 1982, AM J OBSTET GYNECOL, V142, P776

[6] PROGESTOGENS AND CARDIOVASCULAR REACTIONS ASSOCIATED WITH ORAL-CONTRACEPTIVES AND A COMPARISON OF THE SAFETY OF 50-MU-G AND 30-MU-G ESTROGEN PREPARATIONS [J].

MEADE, TW ;

GREENBERG, G ;

THOMPSON, SG .

BRITISH MEDICAL JOURNAL, 1980, 280 (6224) :1157-1161

[7]

SPEROFF L, 1982, JOHNS HOPKINS MED J, V150, P170

[8] EFFECT OF ESTROGEN PROGESTIN POTENCY ON LIPID LIPOPROTEIN CHOLESTEROL [J].

WAHL, P ;

WALDEN, C ;

KNOPP, R ;

HOOVER, J ;

WALLACE, R ;

HEISS, G ;

RIFKIND, B .

NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (15) :862-867

[9]

1982, CONTRACEPTION, V25, P231

← 1 →